Phase 1 Trial of Panobinostat + Ruxolitnib for Relapsed/Refactory Diffused Large B Cell Lymphoma (DLBCL)
Administered By
Awarded By
Contributors
- Dave, Sandeep S. Mentor
- McKinney, Matthew Stuart Principal Investigator
Start/End
- March 1, 2016 - August 31, 2019